Consistent results were obtained in the KRas mutant non-small-cell lung cancer (NSCLC), where DRP1 orchestrated a metabolic rewiring to promote lactate utilization and ROS production suppression [62]. Here, DNM1L is linked to non-small cell lung carcinoma.